Today the total cost of a new product from discovery to launch is estimated at over $1 billion, and around half of this is spent on clinical trials. Any delay in launching a new product can cost a company millions in lost revenue.
As clinical trials move away from the traditional placebo control mechanism, trial coordinators are turning more and more to trials requiring a comparator drug in order to prove superiority to existing treatments. This means that clinical trials |
coordinators need to work with companies that have specialist knowledge of the comparator market and can deliver the right product and presentation for these international multi-centre trials.
Keats has relationships with pharmaceutical manufacturers and worldwide product sourcing partners. This enables us to address your clinical trials needs and work within your time lines, whether it be for comparators, repackaging or distribution direct to site. |
|
